DIAGNOSTIC VALUE OF CIRCULATING IMMUNE COMPLEXES AS INDICATORS OF SYSTEMIC INFLAMMATION IN CHILDREN WITH EPIDERMOLYSIS BULLOSA

Abstract

Epidermolysis bullosa (EB) is a group of rare, genetically determined skin disorders characterized by extreme fragility of the skin and mucous membranes. Although primarily considered a structural disease, increasing evidence supports the involvement of systemic inflammation in its pathogenesis. Circulating immune complexes (CICs), as immune mediators and markers of chronic inflammation, have not been extensively studied in EB, especially in pediatric patients.

Source type: Conferences
Years of coverage from 2022
inLibrary
Google Scholar
126-127
14

Downloads

Download data is not yet available.
To share
Khamraeva, I. ., Aripova, T. ., & Ismailova, A. (2025). DIAGNOSTIC VALUE OF CIRCULATING IMMUNE COMPLEXES AS INDICATORS OF SYSTEMIC INFLAMMATION IN CHILDREN WITH EPIDERMOLYSIS BULLOSA. Academic Research in Modern Science, 4(30), 126–127. Retrieved from https://inlibrary.uz/index.php/arims/article/view/101638
Crossref
Сrossref
Scopus
Scopus

Abstract

Epidermolysis bullosa (EB) is a group of rare, genetically determined skin disorders characterized by extreme fragility of the skin and mucous membranes. Although primarily considered a structural disease, increasing evidence supports the involvement of systemic inflammation in its pathogenesis. Circulating immune complexes (CICs), as immune mediators and markers of chronic inflammation, have not been extensively studied in EB, especially in pediatric patients.


background image

ACADEMIC RESEARCH IN MODERN SCIENCE

International scientific-online conference

126

DIAGNOSTIC VALUE OF CIRCULATING IMMUNE COMPLEXES AS

INDICATORS OF SYSTEMIC INFLAMMATION IN CHILDREN WITH

EPIDERMOLYSIS BULLOSA

Iroda Khamraeva

Tamara Aripova

Adolat Ismailova

Institute of Immunology and Human Genomics, Academy of Sciences of the

Republic of Uzbekistan, Tashkent

https://doi.org/10.5281/zenodo.15574954

Background:

Epidermolysis bullosa (EB) is a group of rare, genetically

determined skin disorders characterized by extreme fragility of the skin and
mucous membranes. Although primarily considered a structural disease,
increasing evidence supports the involvement of systemic inflammation in its
pathogenesis. Circulating immune complexes (CICs), as immune mediators and
markers of chronic inflammation, have not been extensively studied in EB,
especially in pediatric patients.

Keywords:

epidermolysis bullosa, circulating immune complexes, pediatric

inflammation, humoral immunity, immunopathogenesis

Objective:

To evaluate the diagnostic and prognostic significance of CICs of

different molecular sizes in children with EB during exacerbation.

Methods:

The study included 42 children aged 2 to 12 years with clinically

and genetically confirmed EB, hospitalized in the Republican Center of
Dermatology, Uzbekistan. Serum CICs were quantified using a
spectrophotometric method based on precipitation with 3% and 4%
polyethylene glycol (PEG) solutions to distinguish large and small molecular
complexes, respectively. Measurements were conducted within the first two
days of hospitalization before initiating anti-inflammatory therapy. Statistical
significance was evaluated using Student’s t-test.

Results:

The average level of large CICs (3% PEG) in EB patients was 47 ±

1.9 optical density (OD) units compared to 6.5 ± 1.12 in healthy controls,
representing a 7.2-fold increase. Small CICs (4% PEG) were elevated to 39 ± 1.2
OD units vs 4.6 ± 0.88 in controls, indicating an 8.5-fold rise. The CIC3%/CIC4%
ratio increased from 1.1 in healthy children to 1.7 in EB patients, suggesting an
imbalance in immune complex composition and a marker of systemic
inflammation.

Conclusion:

This study demonstrates that both large and small circulating

immune complexes are markedly elevated in pediatric EB during active disease.
The altered ratio of CIC3% to CIC4% reflects an immune imbalance and may


background image

ACADEMIC RESEARCH IN MODERN SCIENCE

International scientific-online conference

127

serve as a valuable biomarker of systemic inflammation in EB. These findings
highlight the potential utility of CIC profiling in disease monitoring and future
personalized interventions.